These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeting the vulnerability to NAD Takao S; Chien W; Madan V; Lin DC; Ding LW; Sun QY; Mayakonda A; Sudo M; Xu L; Chen Y; Jiang YY; Gery S; Lill M; Park E; Senapedis W; Baloglu E; Müschen M; Koeffler HP Leukemia; 2018 Mar; 32(3):616-625. PubMed ID: 28904384 [TBL] [Abstract][Full Text] [Related]
23. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Jang BC; Park JG; Song DK; Baek WK; Yoo SK; Jung KH; Park GY; Lee TY; Suh SI Toxicol In Vitro; 2009 Mar; 23(2):281-7. PubMed ID: 19135517 [TBL] [Abstract][Full Text] [Related]
24. Nicotinamide phosphoribosyltransferase inhibitor APO866 induces C6 glioblastoma cell death via autophagy. Yang P; Zhang L; Shi QJ; Lu YB; Wu M; Wei EQ; Zhang WP Pharmazie; 2015 Oct; 70(10):650-5. PubMed ID: 26601421 [TBL] [Abstract][Full Text] [Related]
25. Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. Fleischer TC; Murphy BR; Flick JS; Terry-Lorenzo RT; Gao ZH; Davis T; McKinnon R; Ostanin K; Willardsen JA; Boniface JJ Chem Biol; 2010 Jun; 17(6):659-64. PubMed ID: 20609415 [TBL] [Abstract][Full Text] [Related]
26. Metabolic effects of the cytotoxic guanidino-containing drug CHS 828 in human U-937 lymphoma cells. Ekelund S; Larsson R; Nygren P Anticancer Res; 2002; 22(4):2269-74. PubMed ID: 12174913 [TBL] [Abstract][Full Text] [Related]
27. Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells. Travelli C; Drago V; Maldi E; Kaludercic N; Galli U; Boldorini R; Di Lisa F; Tron GC; Canonico PL; Genazzani AA J Pharmacol Exp Ther; 2011 Sep; 338(3):829-40. PubMed ID: 21685314 [TBL] [Abstract][Full Text] [Related]
28. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618. Xiao Y; Elkins K; Durieux JK; Lee L; Oeh J; Yang LX; Liang X; DelNagro C; Tremayne J; Kwong M; Liederer BM; Jackson PK; Belmont LD; Sampath D; O'Brien T Neoplasia; 2013 Oct; 15(10):1151-60. PubMed ID: 24204194 [TBL] [Abstract][Full Text] [Related]
29. Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. Ogino Y; Sato A; Uchiumi F; Tanuma SI Oncotarget; 2018 Mar; 9(23):16451-16461. PubMed ID: 29662658 [TBL] [Abstract][Full Text] [Related]
30. Advances in NAD-Lowering Agents for Cancer Treatment. Ghanem MS; Monacelli F; Nencioni A Nutrients; 2021 May; 13(5):. PubMed ID: 34068917 [TBL] [Abstract][Full Text] [Related]
31. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Gomathinayagam R; Sowmyalakshmi S; Mardhatillah F; Kumar R; Akbarsha MA; Damodaran C Anticancer Res; 2008; 28(2A):785-92. PubMed ID: 18507021 [TBL] [Abstract][Full Text] [Related]
32. Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition. Wang W; Hu Y; Yang C; Zhu S; Wang X; Zhang Z; Deng H Mol Cell Proteomics; 2018 Oct; 17(10):2005-2017. PubMed ID: 29980616 [TBL] [Abstract][Full Text] [Related]
33. Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery. Khan JA; Forouhar F; Tao X; Tong L Expert Opin Ther Targets; 2007 May; 11(5):695-705. PubMed ID: 17465726 [TBL] [Abstract][Full Text] [Related]
35. Model for time dependency of cytotoxic effect of CHS 828 in vitro suggests two different mechanisms of action. Hassan SB; Jonsson E; Larsson R; Karlsson MO J Pharmacol Exp Ther; 2001 Dec; 299(3):1140-7. PubMed ID: 11714905 [TBL] [Abstract][Full Text] [Related]
36. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells. Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066 [TBL] [Abstract][Full Text] [Related]
37. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells]. Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697 [TBL] [Abstract][Full Text] [Related]
38. The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro--from cytotoxic synergy to complete inhibition of apoptosis. Martinsson P; Ekelund S; Nygren P; Larsson R Br J Pharmacol; 2002 Oct; 137(4):568-73. PubMed ID: 12359640 [TBL] [Abstract][Full Text] [Related]
39. A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor. Olesen UH; Thougaard AV; Jensen PB; Sehested M Mol Cancer Ther; 2010 Jun; 9(6):1609-17. PubMed ID: 20515945 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of alpha-lipoic acid-induced apoptosis of lung cancer cells. Choi SY; Yu JH; Kim H Ann N Y Acad Sci; 2009 Aug; 1171():149-55. PubMed ID: 19723049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]